DMP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dermapharm Holding SE

Watchlist Manager

Watchlist

Price: 40.05 EUR 0.38% Market Closed

Market Cap: €4.3B

D	Dermapharm Holding SE DUS:DMP	DE
	Meiji Holdings Co Ltd TSE:2269	JP
M	MorphoSys AG XMUN:MOR	DE

Profitability Summary

Dermapharm Holding SE's profitability score is 58/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

64% > 68%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

19%

Declining Operating Margin

22% > 20%

Healthy Net Margin

12%

Low 3Y Average Net Margin

Net Margin is Increasing

11% > 12%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

23% > 21%

Positive ROE

21%

Positive 3Y Average ROE

View All

Hide

Collapse

58 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.